US · NXTS · AGRICULTURAL INPUTS
Nexentis Technologies Inc. (NXTS) intrinsic value and stock valuation
$1.58as of 2026-11-21 · Mkt cap 104.7K
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
Nexentis Technologies Inc. DCF and intrinsic value
InvestorsCraft values NXTS with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from NXTS’s statements →
Nexentis Technologies Inc. Graham Number
The Graham Number is not defined for negative earnings or book value. Guide · Calculator →
How the business is doing
Fiscal 2009–2025, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Financials
Statements by fiscal year
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.00 | $210K | $260K | $390K | $440K |
| Operating income | -$-5.03M | -$-4.05M | -$-7.3M | -$-5.71M | -$-4.54M |
| Net income | -$-4.05M | -$-5.19M | -$-6.52M | -$-5.74M | -$-4.82M |
| EPSd | -$-25.31M | -$-30.53M | -$-217.33M | -$-574M | -$-482M |
| Operating cash flow | -$-3.81M | -$-3.42M | -$-3.23M | -$-5.1M | -$-4.1M |
| Capital expenditure | -$-10K | $0.00 | -$0.00 | -$-50K | -$-70K |
| Free cash flow | -$-3.82M | -$-3.42M | -$-3.23M | -$-5.15M | -$-4.17M |
| Total assets | $20.4M | $5.46M | $7.24M | $6.49M | $7.6M |
| Total debt | $990K | $10K | $50K | $150K | $230K |
| Net debt | -$-2.84M | -$-2.2M | -$-4.42M | -$-5.6M | -$-6.58M |
| Total equity | $15.7M | $4.57M | $6.46M | $5.74M | $6.41M |
| Cash and short-term investments | $4.07M | $2.52M | $4.48M | $5.75M | $6.81M |
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.00 | $210K | $260K | $390K | $440K |
| Cost of revenue | $80K | $180K | $80K | $190K | $190K |
| Gross profit | -$-80K | $30K | $190K | $210K | $240K |
| Research and development expenses | $180K | $370K | $1.93M | $750K | $500K |
| Selling, general and administrative expenses | $5.11M | $3.71M | $5.56M | $5.17M | $4.29M |
| Other expenses | -$-340K | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating expenses | $4.95M | $4.08M | $7.49M | $5.92M | $4.79M |
| Cost and expenses | $5.03M | $4.26M | $7.56M | $6.1M | $4.98M |
| Interest income | $0.00 | $70K | $70K | $0.00 | $0.00 |
| Interest expense | $120K | $100K | $10K | $10K | $40K |
| Depreciation and amortization | $80K | $20K | $20K | $50K | $60K |
| Ebitda | -$-4.95M | -$-4.03M | -$-7.28M | -$-5.66M | -$-4.48M |
| Operating income | -$-5.03M | -$-4.05M | -$-7.3M | -$-5.71M | -$-4.54M |
| Total other income/expenses, net | $1.42M | -$-1.3M | $40K | -$-70K | -$-320K |
| Income before tax | -$-3.61M | -$-5.35M | -$-7.26M | -$-5.78M | -$-4.87M |
| Income tax expense | -$-20K | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | -$-4.05M | -$-5.19M | -$-6.52M | -$-5.74M | -$-4.82M |
| Weighted average shares outstanding | $160K | $170K | $30K | $10K | $10K |
| Weighted average diluted shares outstanding | $160K | $170K | $30K | $10K | $10K |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $4.07M | $2.52M | $4.48M | $5.75M | $6.81M |
| Net receivables | $530K | $380K | $110K | $190K | $170K |
| Inventory | $0.00 | $20K | $120K | $80K | $20K |
| Total current assets | $6.01M | $3.4M | $5.47M | $6.27M | $7.23M |
| Property, plant and equipment, net | $40K | $60K | $120K | $220K | $230K |
| Goodwill and intangible assets | $11.4M | $0.00 | $0.00 | $0.00 | $0.00 |
| Long-term investments | $2.74M | $1.76M | $1.66M | $0.00 | $0.00 |
| Total non-current assets | $14.4M | $2.06M | $1.78M | $220K | $370K |
| Total assets | $20.4M | $5.46M | $7.24M | $6.49M | $7.6M |
| Accounts payable | $10K | $50K | $40K | $420K | $540K |
| Short-term debt | $750K | $10K | $40K | $70K | $50K |
| Deferred revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total current liabilities | $1.43M | $890K | $780K | $710K | $930K |
| Long-term debt | $240K | $0.00 | $10K | $80K | $170K |
| Deferred revenue, non-current | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total non-current liabilities | $3.24M | $0.00 | $10K | $40K | $250K |
| Capital lease obligations | $10K | $0.00 | $10K | $40K | $90K |
| Total liabilities | $4.67M | $890K | $790K | $750K | $1.18M |
| Common stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Retained earnings | -$-38.56M | -$-34.55M | -$-29.36M | -$-22.84M | -$-17.1M |
| Accumulated other comprehensive income (loss) | -$-40K | -$-30K | -$-30K | -$-30K | -$-30K |
| Total equity | $15.7M | $4.57M | $6.46M | $5.74M | $6.41M |
| Total investments | $2.98M | $2.07M | $1.66M | $0.00 | $0.00 |
| Total debt | $990K | $10K | $50K | $150K | $230K |
| Net debt | -$-2.84M | -$-2.2M | -$-4.42M | -$-5.6M | -$-6.58M |
Cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net income | -$-4.16M | -$-5.19M | -$-6.52M | -$-5.74M | -$-4.82M |
| Depreciation and amortization | $70K | $20K | $20K | $50K | $60K |
| Stock-based compensation | $2.15M | $0.00 | $0.00 | $0.00 | $0.00 |
| Change in working capital | -$-100K | $170K | $290K | -$-270K | -$-50K |
| Accounts receivable | $10K | -$-40K | $90K | -$-20K | -$-20K |
| Inventory | $10K | $100K | -$-40K | -$-60K | -$-10K |
| Accounts payable | -$-20K | $10K | -$-90K | -$-120K | $340K |
| Net cash provided by operating activities | -$-3.81M | -$-3.42M | -$-3.23M | -$-5.1M | -$-4.1M |
| Investments in property, plant and equipment | -$-10K | $0.00 | $0.00 | -$-50K | -$-70K |
| Acquisitions, net | -$-2.35M | -$-1.01M | $20K | $0.00 | $0.00 |
| Net cash used for investing activities | -$-3.23M | -$-1.89M | -$-1.52M | -$-50K | -$-80K |
| Common stock issued | $3.33M | $0.00 | $0.00 | $4.1M | $10.5M |
| Common stock repurchased | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net cash used for financing activities | $8.86M | $3.05M | $3.47M | $4.09M | $10.7M |
| Net change in cash | $1.8M | -$-2.27M | -$-1.27M | -$-1.06M | $6.54M |
| Cash at end of period | $4.01M | $2.21M | $4.48M | $5.75M | $6.81M |
| Operating cash flow | -$-3.81M | -$-3.42M | -$-3.23M | -$-5.1M | -$-4.1M |
| Capital expenditure | -$-10K | $0.00 | -$0.00 | -$-50K | -$-70K |
| Free cash flow | -$-3.82M | -$-3.42M | -$-3.23M | -$-5.15M | -$-4.17M |
Line items
Line items
Line items
About Nexentis Technologies Inc.
Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The company's pipeline includes MITOLINE, an algorithm used to perform multiple sequence/ structure pairwise alignments which could then be used for generating a 3D comparative model of potentially all mitochondrial carrier proteins; cloud-based computational chemistry platform; and novel in-vitro screening platforms; and advanced 3D NSCLC tumor spheroid systems.The company was formerly known as N2OFF, Inc. and changed its name to Nexentis Technologies Inc. in February 2026. Nexentis Technologies Inc. was incorporated in 2009 and is headquartered in Ness Ziona, Israel.
- CEO
- David Palach
- Employees
- 7
- Beta
- 1.82
Explore
Frequently asked questions
What is the intrinsic value of Nexentis Technologies Inc. (NXTS)?
InvestorsCraft does not currently publish an intrinsic value for NXTS. How the IC value is calculated.
Is NXTS undervalued?
InvestorsCraft does not publish an undervaluation signal for NXTS at this time.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.